DE69329654D1 - 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen - Google Patents

3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen

Info

Publication number
DE69329654D1
DE69329654D1 DE69329654T DE69329654T DE69329654D1 DE 69329654 D1 DE69329654 D1 DE 69329654D1 DE 69329654 T DE69329654 T DE 69329654T DE 69329654 T DE69329654 T DE 69329654T DE 69329654 D1 DE69329654 D1 DE 69329654D1
Authority
DE
Germany
Prior art keywords
benzimidazole
oxo
carboxyl
pct
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329654T
Other languages
English (en)
Other versions
DE69329654T2 (de
Inventor
E Maryanoff
F Mccomsey
Ho Winston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho McNeil Pharmaceutical Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of DE69329654D1 publication Critical patent/DE69329654D1/de
Application granted granted Critical
Publication of DE69329654T2 publication Critical patent/DE69329654T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69329654T 1992-08-19 1993-08-18 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen Expired - Fee Related DE69329654T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93217692A 1992-08-19 1992-08-19
PCT/US1993/007794 WO1994004532A1 (en) 1992-08-19 1993-08-18 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders

Publications (2)

Publication Number Publication Date
DE69329654D1 true DE69329654D1 (de) 2000-12-14
DE69329654T2 DE69329654T2 (de) 2001-03-15

Family

ID=25461897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329654T Expired - Fee Related DE69329654T2 (de) 1992-08-19 1993-08-18 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen

Country Status (16)

Country Link
US (2) US5639760A (de)
EP (1) EP0656002B1 (de)
JP (1) JP3463935B2 (de)
KR (1) KR100262762B1 (de)
AT (1) ATE197455T1 (de)
AU (1) AU679938B2 (de)
BR (1) BR9306929A (de)
CA (1) CA2142700C (de)
DE (1) DE69329654T2 (de)
DK (1) DK0656002T3 (de)
ES (1) ES2153842T3 (de)
GR (1) GR3035292T3 (de)
HU (1) HU221369B1 (de)
NZ (1) NZ255821A (de)
PT (1) PT656002E (de)
WO (1) WO1994004532A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001501949A (ja) * 1996-10-07 2001-02-13 オーソ―マクニール・フアーマシユーチカル・インコーポレーテツド 中枢神経系疾患を処置することに有用な５―ヘテロ原子を含有するアルキル置換された―３―オキソ―ピリド（１，２―ａ）ベンゾイミダゾール―４―カルボキサミド誘導体
SI0935598T1 (en) * 1996-10-07 2004-04-30 Ortho-Mcneil Pharmaceutical, Inc. 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
US5922731A (en) * 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
AU2003204221B2 (en) * 1997-10-07 2006-07-27 Ortho-Mcneil Pharmaceutical, Inc. Dipyridoimidazolderivatives useful in treating central nervous system disorders
DK1025101T3 (da) 1997-10-07 2003-04-07 Ortho Mcneil Pharm Inc Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
JP2001519351A (ja) * 1997-10-07 2001-10-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 中枢神経系障害の処置において有用なジピリドイミダゾール誘導体
WO1999040092A1 (en) * 1998-02-04 1999-08-12 Neurogen Corporation Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
US6177569B1 (en) 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
CA2341531A1 (en) * 1998-08-25 2000-03-02 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
ATE289593T1 (de) * 1999-05-06 2005-03-15 Neurogen Corp Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
CA2391766A1 (en) * 1999-08-02 2001-02-08 Ortho-Mcneil Pharmaceutical, Inc. C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives usefu l in treating central nervous system disorders
GB0203058D0 (en) 2002-02-09 2002-03-27 Bp Chem Int Ltd Production of olefins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663934B1 (fr) * 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HU221369B1 (en) 2002-09-28
JP3463935B2 (ja) 2003-11-05
CA2142700A1 (en) 1994-03-03
AU5080893A (en) 1994-03-15
HU9500476D0 (en) 1995-04-28
ES2153842T3 (es) 2001-03-16
EP0656002A1 (de) 1995-06-07
EP0656002B1 (de) 2000-11-08
HUT72654A (en) 1996-05-28
ATE197455T1 (de) 2000-11-11
JPH08500594A (ja) 1996-01-23
DK0656002T3 (da) 2000-11-27
US5639760A (en) 1997-06-17
KR100262762B1 (ko) 2000-08-01
GR3035292T3 (en) 2001-04-30
PT656002E (pt) 2001-02-28
WO1994004532A1 (en) 1994-03-03
DE69329654T2 (de) 2001-03-15
BR9306929A (pt) 1999-01-12
AU679938B2 (en) 1997-07-17
NZ255821A (en) 1996-10-28
US6218384B1 (en) 2001-04-17
CA2142700C (en) 2007-01-09

Similar Documents

Publication Publication Date Title
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
TR200001840T2 (tr) Arile bağlı azopolisiklik bileşikler
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
DE69329654T2 (de) 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
ATE226953T1 (de) 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung
ATE216390T1 (de) Neue verbindungen
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
SE9702564D0 (sv) New compounds
SE9702563D0 (sv) Compounds
FI19992038A (fi) Menetelmä atsepinonien valmistamiseksi
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
FR2717812B1 (fr) Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
DE69526726T2 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
DE69521125T2 (de) IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONDERIVATE UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN
DE69824195D1 (de) Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ATE203244T1 (de) Dreikernige kationische platinkomplexe mit antitumor wirkung, und diese enthaltende arzneizusammensetzungen
DE69619868T2 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
DE59103080D1 (de) 9-Amino-2-phenylbicyclo[3.3.1]nonane und 9-Amino-2-phenylbicyclo[3.3.1]-non-2-ene und diese enthaltende therapeutische Mittel.
ATE168697T1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen
MX9804631A (es) Antagonistas quinazolin-4-ona del ampa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee